Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.05.29.728684

Maternal Gut Microbiota Regulates Neonatal Retinal Angiogenesis Through Lactational Metabolic Signalling

Abstract

Early-life vascular development is a tightly regulated process that influences organ maturation and long-term cardiometabolic and neurovascular health. While the maternal microbiome is increasingly recognised as a determinant of neonatal immune, metabolic, and neurodevelopmental programming, its role in developmental angiogenesis remains poorly defined. Here, we investigated whether maternal gut microbiota regulates neonatal retinal vascular development through maternally derived metabolic signals. Using antibiotic-induced dysbiosis with a broad-spectrum antibiotic cocktail consisting of vancomycin, neomycin, metronidazole, amphotericin B, and ampicillin (VNMAA), together with germ-free animals, we assessed retinal angiogenesis at postnatal day 6 (P6) and P12. Maternal microbiome depletion significantly delayed retinal vascular extension at P6 and produced persistent abnormalities in P12 retinal vascular architecture, including reduced deep plexus vascular density, altered descending branch density, and reduced branching complexity after normalisation to vessel density. Whole-genome shotgun sequencing demonstrated pronounced remodelling of the maternal caecal microbiome following antibiotic treatment and reciprocal faecal microbiota transplantation (FMT), whereas P12 pup caecal communities were comparatively limited and did not mirror the dramatic restructuring observed in dams. Restoration of the maternal microbiome by FMT rescued neonatal vascular defects, supporting a causal role for maternal microbial state. Untargeted LC-MS metabolomics of maternal milk identified glycerophospholipid metabolism as a prominent microbiome-sensitive pathway. Choline and related lipid metabolites were prioritised as candidate mediators because of their position within this pathway and their biological relevance to membrane metabolism and endothelial function. In vitro endothelial assays demonstrated that choline modulates endothelial viability and promotes tubule formation. Together, these findings identify a maternal microbiota-milk metabolite-vascular axis regulating neonatal retinal angiogenesis and suggest that lactational metabolic signalling may represent an important mechanism through which maternal microbial ecology shapes offspring vascular development.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dreger, S. A., Kiu, R., Robinson, S. D.. 2026-06-02. Maternal Gut Microbiota Regulates Neonatal Retinal Angiogenesis Through Lactational Metabolic Signalling. https://doi.org/10.64898/2026.05.29.728684

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Nucleosome Core Allostery Governs Chromatin Recognition and Cell Fate

Nucleosomes regulate chromatin folding, accessibility, and factor recruitment. Current models primarily attribute these functions to histone tail modifications, while the core is largely viewed as a structural scaffold. Yet subtle changes within the nucleosome core can produce profound functional consequences, and the mechanisms underlying these effects remain unclear. Here, we describe nucleosome core allostery as a fundamental principle of chromatin regulation that amplifies the impact of minimal nucleosome variations. Leveraging natural differences between H2A.Z variants, we show that the nucleosome core encodes distinct conformational dynamics that propagate allosterically, thereby controlling nucleosome accessibility and recognition by chromatin factors. As a result, a single buried amino acid substitution alone is sufficient to reprogram nucleosome dynamics and bias cell identity. Our findings establish the nucleosome core as an allosteric regulatory module and provide a generalizable framework for how subtle variation within nucleosomes is amplified into diverse biological outcomes in development and disease.

cell biology↗

SOX4 Reprograms Adipose Stromal Cells into a Cancer-Associated Fibroblast-like State to Drive Metabolic Disease

Pathogenic adipose tissue remodeling promotes metabolic disease in obesity, but the mechanisms that establish this unhealthy tissue state remain poorly understood. Here, we show that obesity drives SOX4-dependent reprogramming of mesenchymal stromal cells (MSCs) into cancer-associated fibroblast-like (CAF-like) cells that promote adipose tissue dysfunction. TGF{beta} signaling is elevated in obesity and activates SOX4 in mouse and human MSCs, inducing their conversion to a CAF-like state. In mice, MSC-specific SOX4 activation induces the CAF-like program and exacerbates adipose tissue inflammation and glucose intolerance, whereas Sox4 deletion attenuates inflammation and improves glucose homeostasis during obesity. We further identify the growth factor Midkine (MDK) as a SOX4-regulated paracrine effector produced by CAF-like cells. MDK inhibition in obese mice reduces adipose tissue inflammation and improves metabolic function. Together, these findings define a TGF{beta}-SOX4-MDK stromal signaling axis that drives pathological adipose tissue remodeling in obesity and highlight this pathway as a potential therapeutic target for improving metabolic health.

cell biology↗

PDLIM5 Modulates YAP1 Localisation and Fibrogenic Gene Expression in Hepatic Stellate Cells

Hepatic stellate cells (HSCs) are the key cellular drivers of liver fibrosis. During liver injury and chronic inflammation HSCs adopt an activated phenotype and secrete fibrotic extracellular matrix (ECM) components such as collagen 1. Mechanical cues derived from the fibrotic ECM drive and support the activation of HSCs, via mechanisms that involve integrins and the mechano-sensitive transcriptional regulator YAP1. It is not yet well understood how external mechanical cues are translated into a molecular response that alters YAP1 nuclear shuttling. There is evidence that suggests the PDZ and LIM domain protein (PDLIM) 5 can regulate YAP1 shuttling in human epithelial cells. We therefore investigated whether PDLIM5 is expressed in HSCs and contributes to YAP1 associated HSC mechano-activation. PDLIM5 protein was detected in HSCs in fibrotic human and mouse liver. PDLIM5 transcript and protein were expressed by primary human and mouse HSCs and by the immortalised HSC LX-2 cell line. PDLIM5 localised with actin stress fibres suggesting a role in HSC adhesion. Co-immunoprecipitation and proximity ligation in LX-2 cells support an association between PDLIM5 and YAP1. We used pharmacological (paclitaxel) and genetic (siRNA and CRISPRi) approaches to inhibit PDLIM5 in HSCs. Inhibiting PDLIM5 reduced YAP1 nuclear localisation and fibrotic gene (COL1A1, ACTA2) expression in LX-2 cells. Overall, these data support a role for PDLIM5 in regulating YAP1 localisation and fibrogenic gene expression in HSCs.

cell biology↗